Scintomics
Scintomics GmbH has been innovating and simplifying processes for the production of radiopharmaceuticals since 2006. The well-known GRP module series became part of SCINTOMICS Molecular, Applied Theranostics Technologies (SCI-att) in 2020 when SCI-att acquired the module business from parent company Scintomics, which has been selling and installing fully automated production systems for established radiopharmaceuticals in clinical facilities around the world since 2006.
A brief overview of our portfolio
- Fully automated synthesis modules (GRP®)
- Precursors e.g. PSMA I&T, HA-DOTATATE, PSMA I&S, siPSMA-14, siFalin-TATE, PSMA-11, DOTA-TOC
- Production sets (including cassettes, reagents and consumables) for the GRP® module
- Consumables specially adapted for the GRP® module
More details can be found:
